Successful treatment of stage-IIIB seminoma with single-agent carboplatin therapy.
Single-agent carboplatin chemotherapy has recently been introduced into the therapy of limited seminoma. Because of poor compliance due to Down's syndrome we successfully treated a 32-year-old man with relapsed stage-IIIB seminoma with a dose-modified carboplatin monotherapy schedule leading to complete remission even after a follow-up of 4 years.
Bohle
W
W
Department of Internal Medicine, Katharinenhospital, Stuttgart, Germany.
Ruether
U
U
Rassweiler
J
J
Nunnensiek
C
C
Eisenberger
F
F
Jipp
P
P
D000328:Adult; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D016190:Carboplatin / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D018239:Seminoma / Q000188:drug therapy*; D013736:Testicular Neoplasms / Q000188:drug therapy*
D000970:Antineoplastic Agents; D016190:Carboplatin